Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 13(2): e0192588, 2018.
Article in English | MEDLINE | ID: mdl-29447201

ABSTRACT

This study was conducted to develop an equation for estimation of 24-h urinary-sodium excretion that can serve as an alternative to 24-h dietary recall and 24-h urine collection for normotensive Korean adults. In total, data on 640 healthy Korean adults aged 19 to 69 years from 4 regions of the country were collected as a training set. In order to externally validate the equation developed from that training set, 200 subjects were recruited independently as a validation set. Due to heterogeneity by gender, we constructed a gender-specific equation for estimation of 24-h urinary-sodium excretion by using a multivariable linear regression model and assessed the performance of the developed equation in validation set. The best model consisted of age, body weight, dietary behavior ('eating salty food', 'Kimchi consumption', 'Korean soup or stew consumption', 'soy sauce or red pepper paste consumption'), and smoking status in men, and age, body weight, dietary behavior ('salt preference', 'eating salty food', 'checking sodium content for processed foods', 'nut consumption'), and smoking status in women, respectively. When this model was tested in the external validation set, the mean bias between the measured and estimated 24-h urinary-sodium excretion from Bland-Altman plots was -1.92 (95% CI: -113, 110) mmol/d for men and -1.51 (95% CI: -90.6, 87.6) mmol/d for women. The cut-points of sodium intake calculated based on the equations were ≥4,000 mg/d for men and ≥3,500 mg/d for women, with 89.8 and 76.6% sensitivity and 29.3 and 64.2% specificity, respectively. In this study, a habitual 24-hour urinary-sodium-excretion-estimation model of normotensive Korean adults based on anthropometric and lifestyle factors was developed and showed feasibility for an asymptomatic population.


Subject(s)
Blood Pressure , Models, Theoretical , Sodium/urine , Adult , Aged , Female , Humans , Male , Middle Aged , Republic of Korea , Surveys and Questionnaires , Young Adult
2.
Eur J Pharmacol ; 485(1-3): 333-9, 2004 Feb 06.
Article in English | MEDLINE | ID: mdl-14757158

ABSTRACT

Protein tyrosine phosphatase-1B (PTP-1B), a negative regulator of insulin signaling, may be an attractive therapeutic target for type 2 diabetes mellitus. High throughput screening (HTS) for PTP-1B inhibitors using compounds from the Korea Chemical Bank identified several hits (active compounds). Among them, a hit with 1,2-naphthoquinone scaffold was chosen for lead development. KR61639, [4-[1-(1H-indol-3-yl)-3,4-dioxo-3,4-dihydro-naphthalen-2-ylmethyl]-phenoxy]-acetic acid tert-butyl ester, inhibited human recombinant PTP-1B with an IC(50) value of 0.65 microM in a noncompetitive manner. KR61639 showed modest selectivity over several phosphatases and increased insulin-stimulated glycogen synthesis in HepG2 cells and stimulated 2-deoxyglucose uptake in 3T3/L1 adipocytes. In addition, in vivo study using ob/ob mouse demonstrated that KR61639 exerted a hypoglycemic action when given orally. Thus, KR61639 may be a good starting point for lead optimization in developing a novel antidiabetic agent.


Subject(s)
Drug Design , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/pharmacology , Indoles/chemistry , Indoles/pharmacology , Naphthalenes/chemistry , Naphthalenes/pharmacology , Protein Tyrosine Phosphatases/antagonists & inhibitors , 3T3-L1 Cells , Adipocytes/drug effects , Adipocytes/enzymology , Animals , Cell Line, Tumor , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Inhibitors/therapeutic use , Humans , Hyperglycemia/metabolism , Hyperglycemia/prevention & control , Hypoglycemic Agents/therapeutic use , Insulin/pharmacology , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , Mice , Mice, Obese , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatases/metabolism
3.
Korean J Parasitol ; 41(2): 97-100, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12815320

ABSTRACT

Acute gastric anisakiasis with multiple anisakid larvae infection is reported. A 68-year-old woman residing in Busan, Korea, had epigastric pain with severe vomiting about 5 hours after eating raw anchovies. Four nematode larvae penetrating the gastric mucosae in the great curvature of the middle body and fundus were found and removed during gastro-endoscopic examination. Another one thread-like moving larva was found in the great curvature of upper body on the following day. On the basis of their morphology, the worms were identified as the 3rd stage larvae of Anisakis simplex. This case is acute gastric anisakiasis provoking severe clinical problems by the multiple infection and the greatest number of anisakid larvae found in a patient in Korea.


Subject(s)
Anisakiasis/parasitology , Anisakis/growth & development , Stomach Diseases/parasitology , Acute Disease , Aged , Animals , Anisakiasis/surgery , Female , Gastric Mucosa/parasitology , Gastric Mucosa/pathology , Gastric Mucosa/surgery , Gastroscopy , Humans , Stomach Diseases/pathology , Stomach Diseases/surgery
4.
J Biochem Mol Biol ; 35(5): 518-23, 2002 Sep 30.
Article in English | MEDLINE | ID: mdl-12359096

ABSTRACT

Nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenase, inhibits the secretion of proteins and causes the redistribution of resident Golgi proteins into the endoplasmic reticulum (ER). In this study, the effect of NDGA on lipoprotein lipase (LPL) secretion was investigated in 3T3-L1 adipocytes, and compared with those of brefeldin A (BFA), a well-known fungal metabolite that exhibits similar ER-Golgi redistribution. Both BFA and NDGA blocked secretions of LPL. In the presence of BFA, the active and dimeric LPL was accumulated in adipocytes. After endoglycosidase H (endo H) digestion, the proportion of LPL subunits with partially endo H-sensitive oligosaccharide was significantly increased with BFA. However, in the presence of NDGA, the cellular LPL became inactive, and only the endo H-sensitive fraction of the LPL subunit was observed. An increase of the aggregated forms was observed in the fractions of the sucrose-density gradient ultracentrifugation. These properties of LPL in the NDGA-treated cells were similar to those of LPL that is retained in ER, and the effects of NDGA could not be reversed by BFA. These results indicate that the inhibitory mechanism of NDGA on the LPL secretion is functionally different from the ER-Golgi redistribution that is induced by BFA.


Subject(s)
Lipoprotein Lipase/metabolism , Masoprocol/pharmacology , 3T3 Cells , Animals , Brefeldin A/pharmacology , Endoplasmic Reticulum/metabolism , Golgi Apparatus/metabolism , Lipoprotein Lipase/antagonists & inhibitors , Lipoxygenase Inhibitors/pharmacology , Mice , Protein Transport
SELECTION OF CITATIONS
SEARCH DETAIL
...